ATHE: Kapitalisasi pasar alteritytherapeutics.com

Alterity Therapeutics specializes in discovering therapies for rare brain pathologies. The price action history shown below is based on the 0.05 metric. The business focuses on developing agents to remove excess iron from brain tissues to slow cell death in Parkinson's disease. The primary growth driver will be the upcoming results of Phase II trials for the key drug candidate.

Alterity Therapeutics Ltd. - Nilai pasar ATHE (periode 04.07.2022 - 22.10.2026)

ATHE (alteritytherapeutics.com): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Alterity Therapeutics (ATHE):

Kutipan saham Alterity Therapeutics Limited|ATHE - Rega prakiraan analis|Kapitalisasi pasar Alterity Therapeutics Limited

Analisis fundamental perusahaan:ATHE (Alterity Therapeutics Ltd)

Sampel barang Alterity Therapeutics Ltd.

Market capitalization reflects the aggregate value of all shares, measuring current market confidence in the company's assets. The dynamics of this indicator allow for an assessment of business resilience during periods of volatility. By analyzing the market capitalization trend of the company, an investor sees a real-time operational reassessment of risks. For Alterity Therapeutics (ATHE), this metric captures the market reaction to strategic alliances with Parkinson's disease research centers, demonstrating the capitalization of potential in the fight against neurodegeneration.

Pesaing wigati

Biogen - Biji pasar|Nilai pasar NBIX (Neurocrine)|Regencell - Kapitalisasi pasar|Nilai pasar AXSM (Axsome Corp)|ACAD: Kapitalisasi pasar|Nilai pasar xenon-pharma.com (XENE)|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|DNLI - Nilai pasar|Harmony Biosciences - Biji pasar|Kapitalisasi pasar biohavenpharma.com BHVN|AMLX - Nilai pasar|Nilai pasar TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Nilai pasar|Nilai pasar Anavex Life Sciences Corp (AVXL)|CBLL (CeriBell, Inc.) - Kapitalisasi pasar|Kapitalisasi pasar Prothena Corp|Nilai pasar Alector, Inc. (ALEC)|Nilai pasar ANNX (Annexon Biosciences)|Omeros - Biji pasar|Nilai pasar NGNE (Neurogene Therapeutics)|AC Immune - Kapitalisasi pasar|Nilai pasar voyagertherapeutics.com|Neumora Therapeutics, Inc. (NMRA) - Nilai pasar|Scilex Holding - Nilai pasar|TVGN (Tevogen Bio Holdings, Inc.) - Kapitalisasi pasar|Alpha Cognition Corp (ACOG) - Kapitalisasi pasar|Biji pasar CGTX (Cognition Therapeutics, Inc.)|Nilai pasar IKT|Cassava Sciences - Biji pasar|Assertio Holdings (ASRT) - Nilai pasar|COYA: Biji pasar|Nilai pasar VTGN (Vistagen Therapeutics)|OVID (ovidrx.com) - Biji pasar|ABOS: Nilai pasar|CRVO (CervoMed) - Kapitalisasi pasar|CLNN: Nilai pasar|Kapitalisasi pasar PEPG|JUNS - Nilai pasar|Nilai pasar Relmada Therapeutics RLMD|Nilai pasar ANVS|Grace Tx - Kapitalisasi pasar|AIFF - Kapitalisasi pasar|anewmeds.com (KLTO) - Nilai pasar|Biji pasar NRSN (NeuroSense Therapeutics Ltd.)|RVPH (Reviva Pharmaceuticals) - Kapitalisasi pasar|Nilai pasar MetaVia, Inc. MTVA|Biji pasar NRXS (NeurAxis)|Kapitalisasi pasar heliusmedical.com (HSDT)|Passage Bio - Biji pasar|Nilai pasar NEUP (Neuphoria Therapeutics, Inc.)|Minerva Neurosciences - Kapitalisasi pasar|Kapitalisasi pasar athira.com ATHA|ADXN: Kapitalisasi pasar|Biji pasar Alzamend Neuro|Nilai pasar Cyclerion Therapeutics Inc.|Protagenic (PTIX) - Kapitalisasi pasar|Kapitalisasi pasar KTTA|Kapitalisasi pasar cortigent.com (CRGT)|Avenue Therapeutics, Inc. - Biji pasar|Nilai pasar BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc - Kapitalisasi pasar|Nilai pasar CHRO (Chromocell)|ELYM: Kapitalisasi pasar|Nilai pasar Intra-Cellular Therapies, Inc. (ITCI)|Nilai pasar Longboard Pharmaceuticals, Inc.|Kapitalisasi pasar MRNS (Marinus Pharmaceuticals Inc)|Kapitalisasi pasar NKGN|NRBO - Nilai pasar|Sage Therapeutics, Inc. - Biji pasar|Kapitalisasi pasar synaptogen.com SNPX|TRVN - Nilai pasar|Nilai pasar VIGL (Vigil Neuroscience)|Anew Medical, Inc. (WENA) - Nilai pasar|Nilai pasar Cerevel Corp (CERE)